Founded in 1999, Sam Brown Inc. is a full-service, independent healthcare communications agency that provides strategic communications services to a wide range of biotechnology, pharmaceutical and venture capital companies whose cutting-edge science and innovation span all phases of the life science continuum – from launch and discovery research through late-stage clinical development to product launches and commercialization.
The trial testing the immune response of co-administration of GSK’s blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study.
The deal gives Organon VTAMA cream, a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis.
The experimental device “will enable even those who have lost both eyes and their optic nerve to see,” Musk said in a post on X.
U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk’s diabetes drug for less than $100 a month.
Rooted in Hill Holliday’s health legacy, Hill Holliday Quest fuses behavioral science, strategic insight, creative, social and media to design human-centric solutions that resonate and drive behavior change.